RecruitingNot ApplicableNCT05968573

Persuasive Health Communication Intervention for HIV/HCV

Evaluation of a Persuasive Health Communication Intervention Designed to Increase HIV/HCV Screening Among Emergency Departments Patients Who Currently, Formerly or Never Injected Drugs.


Sponsor

University of South Florida

Enrollment

2,000 participants

Start Date

Dec 4, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In this R01 project, the research team will assess how well a promising, easy-to-use, one-time, minimal-training-needed, very brief persuasive health communication intervention (PHCI) increases acceptance of testing among adult ED patients who either currently, formerly or never injected drugs and initially declined HIV/HCV screening. The research team will conduct a randomized, controlled trial (RCT) at EDs within the Mount Sinai Health System to compare the efficacy of the PHCI when delivered by a video vs. an HIV/HCV counselor. Patients who initially declined HIV/HCV screening will be stratified by injection-drug use (IDU) history cohorts: (1) current/former PWIDs, (2) never/non-PWIDs. Within each IDU history cohort, the research team will randomly assign participants (1:1:1) to a PHCI delivered by: (1) a video with captions, (2) a video without captions, (3) an HIV/HCV counselor. This R01 project will be conducted at Mount Sinai affiliate hospitals EDs. For Aim 2, the research team will determine if screening acceptance is similar across IDU history cohorts. For Aim 3, the research team will further compare the two delivery forms of the PHCI through a health economics assessment, both independent of IDU history and within each IDU history cohort.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial tests whether a targeted communication intervention can encourage people who have never been tested for HIV or hepatitis C (HCV) to get screened. You may be eligible if... - You are 18 or older - You speak English or Spanish and can give informed consent - You have NOT been diagnosed with both HIV and HCV - You are NOT already enrolled in another HIV or HCV study - You have NOT been tested for HIV or HCV in the past 12 months You may NOT be eligible if... - You are under 18 - You cannot speak English or Spanish - You are already HIV or HCV positive - You are enrolled in another HIV or HCV research study - You have been tested for HIV or HCV within the past 12 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVideo Format with Captions

A video with captions created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.

OTHERVideo Format without Captions

A video without captions created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.

OTHERHealth Educator

The video created by the research will be compared to a healthcare provider in terms of effectiveness in getting patients screened for HIV/HCV.


Locations(1)

Icahn School of Medicine at Mount Sinai

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05968573


Related Trials